These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 20796157)

  • 61. Diabetes mellitus in chronic hepatitis B and C: prevalence and potential association with the extent of liver fibrosis.
    Papatheodoridis GV; Chrysanthos N; Savvas S; Sevastianos V; Kafiri G; Petraki K; Manesis EK
    J Viral Hepat; 2006 May; 13(5):303-10. PubMed ID: 16637860
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Noninvasive markers to diagnose cirrhosis in patients with HBeAg positive chronic hepatitis: Do new biomarkers improve the accuracy?
    Park SH; Kim DJ; Cheong JY; Cho SW; Hwang SG; Lee YJ; Cho M; Yang JM; Kim YB
    Clin Biochem; 2010 Jul; 43(10-11):877-81. PubMed ID: 20433821
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Can we predict the degree of fibrosis in chronic hepatitis C patients using routine blood tests in our daily practice?
    Cheung RC; Currie S; Shen H; Bini EJ; Ho SB; Anand BS; Hu KQ; Wright TL; Morgan TR;
    J Clin Gastroenterol; 2008 Aug; 42(7):827-34. PubMed ID: 18285716
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Transient elastography: a new surrogate marker of liver fibrosis influenced by major changes of transaminases.
    Coco B; Oliveri F; Maina AM; Ciccorossi P; Sacco R; Colombatto P; Bonino F; Brunetto MR
    J Viral Hepat; 2007 May; 14(5):360-9. PubMed ID: 17439526
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Noninvasive markers of fibrosis and inflammation in clinical practice: prospective comparison with liver biopsy.
    Anastasiou J; Alisa A; Virtue S; Portmann B; Murray-Lyon I; Williams R
    Eur J Gastroenterol Hepatol; 2010 Apr; 22(4):474-80. PubMed ID: 19887952
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Replacement of hystological findings: serum hyaluronic acid for fibrosis, high-sensitive C-reactive protein for necroinflamation in chronic viral hepatitis.
    Yilmaz S; Bayan K; Tüzün Y; Dursun M; Kaplan A; Ozmen S; Canoruç F; Akkuş Z
    Int J Clin Pract; 2007 Mar; 61(3):438-43. PubMed ID: 17313611
    [TBL] [Abstract][Full Text] [Related]  

  • 67. The mean platelet volume is a potential biomarker for cirrhosis in chronic hepatitis B virus infected patients.
    Qi XT; Wan F; Lou Y; Ye B; Wu D
    Hepatogastroenterology; 2014; 61(130):456-9. PubMed ID: 24901161
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Noninvasive scoring algorithm to identify significant liver fibrosis among treatment-naive chronic hepatitis C patients.
    Koller T; Kollerova J; Huorka M; Meciarova I; Payer J
    Eur J Gastroenterol Hepatol; 2014 Oct; 26(10):1108-15. PubMed ID: 25188444
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Hyaluronic acid, transforming growth factor-beta1 and hepatic fibrosis in patients with chronic hepatitis C virus and human immunodeficiency virus co-infection.
    Sanvisens A; Serra I; Tural C; Tor J; Ojanguren I; Barluenga E; Rey-Joly C; Clotet B; Muga R
    J Viral Hepat; 2009 Jul; 16(7):513-8. PubMed ID: 19200132
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Clinical and pathological factors associated with the development of hepatocellular carcinoma in patients with hepatitis virus-related cirrhosis: a long-term follow-up study.
    Rodríguez-Díaz JL; Rosas-Camargo V; Vega-Vega O; Morales-Espinosa D; Mendez-Reguera A; Martínez-Tlahuel JL; Gamboa-Domínguez A; Arrieta O
    Clin Oncol (R Coll Radiol); 2007 Apr; 19(3):197-203. PubMed ID: 17359907
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Prediction on liver fibrosis using different APRI thresholds when patient age is a categorical marker in patients with chronic hepatitis B.
    Liu HB; Zhou JP; Zhang Y; Lv XH; Wang W
    Clin Chim Acta; 2011 Jan; 412(1-2):33-7. PubMed ID: 20828546
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Predicting significant fibrosis in hepatitis C patients in Luxembourg using serological markers.
    Mossong J; Bill S; Hawotte K; Gilson G; Knolle U; Weber J; Roskams T; Arendt V
    Bull Soc Sci Med Grand Duche Luxemb; 2011; (1):19-30. PubMed ID: 21634219
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Short-term and long-term vital outcomes of cirrhotic patients admitted to an intensive care unit.
    Filloux B; Chagneau-Derrode C; Ragot S; Voultoury J; Beauchant M; Silvain C; Robert R
    Eur J Gastroenterol Hepatol; 2010 Dec; 22(12):1474-80. PubMed ID: 21389797
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Assessment of fibrosis and cirrhosis in liver biopsies: an update.
    Germani G; Hytiroglou P; Fotiadu A; Burroughs AK; Dhillon AP
    Semin Liver Dis; 2011 Feb; 31(1):82-90. PubMed ID: 21344353
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Gamma-glutamyl transpeptidase to cholinesterase and platelet ratio in predicting significant liver fibrosis and cirrhosis of chronic hepatitis B.
    Liu D; Li J; Lu W; Wang Y; Zhou X; Huang D; Li X; Ding R; Zhang Z
    Clin Microbiol Infect; 2019 Apr; 25(4):514.e1-514.e8. PubMed ID: 29906588
    [TBL] [Abstract][Full Text] [Related]  

  • 76. [Establishment and evaluation of noninvasive diagnostic models for liver fibrosis in patients with chronic hepatitis B].
    Yang Q; Liu DP; Li LP; Gu Y; Zhang MX; Liu Y; Yang K
    Zhonghua Gan Zang Bing Za Zhi; 2017 Jan; 25(1):15-20. PubMed ID: 28297773
    [No Abstract]   [Full Text] [Related]  

  • 77. Diagnostic accuracy of hepatic venous pressure gradient measurement in the prediction of stage 1 compensated liver cirrhosis in patients with chronic hepatitis B.
    Suk KT; Kim HC; Namkung S; Han SH; Choi KC; Park SH; Sung HT; Kim CH; Kim SH; Ham YL; Kang HM; Kim DJ
    Eur J Gastroenterol Hepatol; 2013 Oct; 25(10):1170-6. PubMed ID: 23603784
    [TBL] [Abstract][Full Text] [Related]  

  • 78. C-reactive protein-to-albumin ratio is a predictor of hepatitis B virus related decompensated cirrhosis: time-dependent receiver operating characteristics and decision curve analysis.
    Huang SS; Xie DM; Cai YJ; Wu JM; Chen RC; Wang XD; Song M; Zheng MH; Wang YQ; Lin Z; Shi KQ
    Eur J Gastroenterol Hepatol; 2017 Apr; 29(4):472-480. PubMed ID: 27984322
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Non-invasive fibrosis score for hepatitis delta.
    Lutterkort GL; Wranke A; Yurdaydin C; Budde E; Westphal M; Lichtinghagen R; Stift J; Bremer B; Hardtke S; Keskin O; Idilman R; Koch A; Manns MP; Dienes HP; Wedemeyer H; Heidrich B
    Liver Int; 2017 Feb; 37(2):196-204. PubMed ID: 27428078
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Usefulness of multiple biomarkers for the prediction of significant fibrosis in chronic hepatitis B.
    Park SH; Kim CH; Kim DJ; Suk KT; Cheong JY; Cho SW; Hwang SG; Lee YJ; Cho M; Yang JM; Kim YB
    J Clin Gastroenterol; 2011 Apr; 45(4):361-5. PubMed ID: 21301354
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.